Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Clinical trial NCT03679884 · COMPLETED
Trial details
- NCT number
- NCT03679884
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2021-02-22
- Enrollment
- 804
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.